8 03, 2024

Decode Health Biomarker Discovery Platform Advances Findings in MS and NMO

2024-03-08T15:55:17-06:00

Decode Health deployed its biomarker discovery platform, incorporating machine learning, to provide new insights into multiple sclerosis (MS) and neuromyelitis optica (NMO). The Decode platform identified disease-specific RNA biomarkers and connections between RNA expression [read more...]

Decode Health Biomarker Discovery Platform Advances Findings in MS and NMO2024-03-08T15:55:17-06:00
7 02, 2023

Healthcare AI: Accelerating Innovation to Advance Precision Medicine

2023-04-24T11:47:38-05:00

For decades, healthcare and policy leaders have developed plans to reduce federal healthcare spending, which reached $4.3 trillion in 2021. Given recent economic shifts globally and domestically, finding solutions to mitigate healthcare costs has become even more important. Few sustainable solutions exist, and additional, more complex healthcare issues continue to emerge.

Healthcare AI: Accelerating Innovation to Advance Precision Medicine2023-04-24T11:47:38-05:00
23 11, 2022

Decode Health’s Key Takeaways from HLTH 2022

2023-04-24T11:47:38-05:00

Last week’s fifth annual HLTH conference in Las Vegas was the biggest and boldest yet. The event was overflowing with interesting information and innovative ideas that push to define healthcare for the next decade. Many of the topics discussed tie directly to the work we do at Decode Health. Here are our team’s takeaways.

Decode Health’s Key Takeaways from HLTH 20222023-04-24T11:47:38-05:00
30 08, 2022

Biomarker Discovery to Improve Clinical Trials and Advance Precision Medicine

2023-04-24T11:47:39-05:00

In the U.S., the cost of chronic diseases is more than $3.7T1 annually. Massive amounts of healthcare data are generated through wearable data, healthcare claims, electronic health records, and even complex genomic datasets. By 2025, the average individual will accumulate more than 4,900 daily digital device interactions2. Data alone, however, isn't the answer. The key is to find patterns within the data to proactively intervene and reduce the inefficiency within the $808 billion3 healthcare industry.

Biomarker Discovery to Improve Clinical Trials and Advance Precision Medicine2023-04-24T11:47:39-05:00
27 05, 2021

Battling the Economic Toll of SARS-CoV-2 with Predictive Analytics

2023-04-24T11:47:41-05:00

According to an article in the Journal of the American Medical Association (JAMA), two Harvard economists estimate the cumulative financial costs of the COVID-19 pandemic at more than $16 trillion. To put this number into perspective, that’s approximately 90% of annual GDP of the United States or $200,000 for a family of four. This is a combination of lost income due to the COVID-induced recession and the economic effect of a shorter, less healthy life.

Battling the Economic Toll of SARS-CoV-2 with Predictive Analytics2023-04-24T11:47:41-05:00
7 12, 2020

Addressing the Emergent Issue of Long COVID

2023-04-24T11:47:41-05:00

Although COVID-19 hospitalizations and death rates have dominated the media, another challenge has quietly emerged during the pandemic. Some COVID patients are reporting a wide variety of debilitating symptoms, often lasting months after being diagnosed. [read more...]

Addressing the Emergent Issue of Long COVID2023-04-24T11:47:41-05:00
28 05, 2019

Illuminating an Invisible Epidemic: Addressing Cost Drivers in Diagnosis and Treatment of Autoimmune Diseases and Disorders

2023-04-24T11:47:43-05:00

Everyone knows at least one person with an autoimmune disease or disorder and just may not know it. Even if you think you don’t, you most likely do, considering autoimmune diseases affect approximately 50 million [read more...]

Illuminating an Invisible Epidemic: Addressing Cost Drivers in Diagnosis and Treatment of Autoimmune Diseases and Disorders2023-04-24T11:47:43-05:00
Go to Top